Study guide

Section 6.2: Anxiety, Trauma-Related, and Obsessive-Compulsive Disorders

NCCPA PANCE Physician Assistant Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular System

1.1 Hypertension (Essential & Secondary) 1.2 Coronary Artery Disease & Myocardial Infarction 1.3 Heart Failure & Cardiomyopathy 1.4 Cardiac Arrhythmias & Conduction Disorders 1.5 Valvular Heart Disease 1.6 Vascular Diseases (Aortic Aneurysm, PAD, DVT) 1.7 Congenital Heart Disease (ASD, VSD, PDA, Coarctation, Tetralogy of Fallot)

2 Chapter 2: Pulmonary System

Section 2.1: Asthma & Bronchospastic Disease Section 2.2: Chronic Obstructive Pulmonary Disease (COPD) Section 2.3: Infectious Pulmonary Disorders (Pneumonia & Tuberculosis) Section 2.4: Restrictive, Vascular & Neoplastic Pulmonary Conditions

3 Chapter 3: Gastrointestinal/Nutrition

3.1 Esophageal & Gastric Disorders (GERD, PUD) 3.2 Hepatic, Biliary & Pancreatic Disorders 3.3 Small & Large Bowel Disorders (IBD, Diverticulitis, Obstruction) 3.4 Colorectal Neoplasms & Nutritional Deficiencies

4 Chapter 4: Musculoskeletal System

Section 4.1: Rheumatologic & Autoimmune MSK Conditions (RA, Lupus, Gout, OA) Section 4.2: Infectious & Inflammatory MSK Disorders (Osteomyelitis, Septic Arthritis) Section 4.3: Bone & Joint Disorders (Fractures, Osteoporosis, Fibromyalgia) Section 4.4: Spine and Soft Tissue Pathology (Low Back Pain, Tendonitis)

5 Chapter 5: Neurologic System

Section 5.1: Cerebrovascular Disease (Stroke, TIA) Section 5.2: Seizure Disorders & Epilepsy Section 5.3: Demyelinating & Neurodegenerative Diseases Section 5.4: Headache Syndromes & Cranial Nerve Disorders

6 Chapter 6: Psychiatry/Behavioral Science

Section 6.1: Depressive and Bipolar Disorders Section 6.2: Anxiety, Trauma-Related, and Obsessive-Compulsive Disorders Section 6.3: Schizophrenia and Psychotic Disorders Section 6.4: Eating, Substance Use, and Personality Disorders

7 Chapter 7: Infectious Diseases

7.1 Viral Infections (HIV, EBV, Influenza) 7.2 Bacterial & Spirochetal Infections (Sepsis, Meningitis) 7.3 Fungal & Parasitic Infections 7.4 Tick-Borne Diseases (Lyme, Rocky Mountain Spotted Fever)

8 Chapter 8: Reproductive System

8.1 Obstetrics: Normal Pregnancy & Prenatal Care 8.2 Obstetrics: Pregnancy Complications 8.3 Gynecology: Menstruation, Menopause, PCOS, and Vaginal Infections

9 Chapter 9: Endocrine System

Section 9.1: Diabetes Mellitus & Acute Complications Section 9.2: Thyroid Disorders & Goiter Section 9.3: Adrenal & Pituitary Disorders

10 Chapter 10: Eyes, Ears, Nose, and Throat

Section 10.1: Ophthalmic Disorders (Glaucoma, Conjunctivitis, Cataracts) Section 10.2: Otic Disorders (Otitis Media/Externa, Vertigo, Labyrinthitis) Section 10.3: Nose, Sinus, and Throat Complaints (Sinusitis, Pharyngitis, Epiglottitis)

11 Chapter 11: Professional Practice

11.1 Bioethics & Legal Standards (Informed Consent, Autonomy, HIPAA) 11.2 Patient Safety, Quality Improvement, and Communication 11.3 Evidence-Based Medicine & Clinical Practice Guidelines

12 Chapter 12: Hematologic System

Section 12.1: Anemias (Microcytic, Macrocytic, Hemolytic/Sickle Cell) Section 12.2: Coagulation and Bleeding Disorders (ITP, TTP, Hemophilia, vWD) Section 12.3: Hematologic Malignancies (Leukemia, Lymphoma, Multiple Myeloma)

13 Chapter 13: Renal System

13.1 Acute Kidney Injury (AKI) & Chronic Kidney Disease (CKD) 13.2 Acid-Base and Electrolyte Disorders 13.3 Glomerular & Tubulointerstitial Diseases

14 Chapter 14: Dermatologic System

Section 14.1: Inflammatory & Autoimmune Skin Conditions Section 14.2: Infectious Skin Conditions Section 14.3: Skin Neoplasms & Burn Management

15 Chapter 15: Genitourinary System

Section 15.1: Male Genitourinary Disorders (BPH, Prostate Cancer, Testicular Torsion, ED) Section 15.2: Urinary Incontinence, Nephrolithiasis, and GU Trauma

Section 6.2: Anxiety, Trauma-Related, and Obsessive-Compulsive Disorders

Key Takeaways Explain This Topic AI

Panic Disorder requires recurrent, unexpected panic attacks and at least 1 month of persistent worry about future attacks.

Generalized Anxiety Disorder (GAD) is characterized by excessive, uncontrollable worry for at least 6 months with somatic symptoms.

Post-Traumatic Stress Disorder (PTSD) symptoms must persist for at least 1 month; less than 1 month is diagnosed as Acute Stress Disorder.

Obsessive-Compulsive Disorder (OCD) is ego-dystonic and treated with high-dose SSRIs and Exposure and Response Prevention (ERP).

Last updated: July 2026

Why Anxiety, Trauma-Related, and Obsessive-Compulsive Disorders Matter for the PANCE

Anxiety disorders constitute the most common class of psychiatric conditions in the United States, making them highly testable on the PANCE. Clinicians must be expert in differentiating normal anxiety from pathological conditions. PANCE focuses heavily on identifying panic attacks versus Panic Disorder, recognizing the specific diagnostic timelines required by the DSM-5-TR (e.g., 6 months of excessive anxiety for Generalized Anxiety Disorder, 1 month for Post-Traumatic Stress Disorder), understanding the clinical manifestations of Obsessive-Compulsive Disorder (OCD), and selecting first-line pharmacotherapy (SSRIs/SNRIs) and appropriate non-pharmacological interventions like Cognitive Behavioral Therapy (CBT).

  • Panic Disorder
  • Pathophysiology and Clinical Presentation

A panic attack is an abrupt surge of intense fear or discomfort that peaks within minutes, during which four or more somatic or cognitive symptoms occur. Panic Disorder is diagnosed when a patient experiences recurrent, unexpected panic attacks, followed by at least 1 month of one or both of the following:

Persistent concern or worry about additional panic attacks or their consequences (e.g., losing control, having a heart attack, 'going crazy').

A significant maladaptive change in behavior related to the attacks (e.g., avoidance of exercise or unfamiliar situations, which may develop into agoraphobia).

Somatic symptoms of a panic attack include:

Cardiovascular: Palpitations, pounding heart, accelerated heart rate, chest pain/discomfort.

Respiratory: Shortness of breath, smothering sensations, choking feeling.

Neurological: Trembling/shaking, paresthesias (numbness/tingling), dizziness, lightheadedness, syncope.

Psychological: Derealization (feelings of unreality), depersonalization (being detached from oneself), fear of losing control, and fear of dying.

Diagnostic Workup

Due to the overwhelming somatic symptoms, patients often present to the emergency department convinced they are having a life-threatening medical event (e.g., myocardial infarction). It is mandatory to rule out medical mimics.

Electrocardiogram (EKG) : To rule out arrhythmia, ischemic changes, or prolonged QT.

Thyroid Function Tests (TSH) : To rule out hyperthyroidism, which causes tachycardia and anxiety.

Urine Drug Screen (UDS) : To rule out stimulant use (cocaine, amphetamines) or withdrawal.

Serum Glucose : To rule out hypoglycemia.

Pheochromocytoma Screen (when indicated) : Elevated urinary catecholamines or plasma metanephrines.

Clinical Management

Acute Management : Short-acting benzodiazepines (e.g., alprazolam, lorazepam) provide rapid relief of severe symptoms. However, they should be used strictly for acute rescue, not long-term maintenance, due to the high risk of tolerance, physical dependence, and abuse.

Long-Term Management : First-line pharmacotherapy is SSRIs (e.g., sertraline, paroxetine, escitalopram). SSRIs require 4-6 weeks to achieve therapeutic efficacy, during which a temporary benzodiazepine bridge is sometimes utilized.

Non-Pharmacologic : Cognitive Behavioral Therapy (CBT) is highly effective and focuses on restructuring catastrophic misinterpretations of physical sensations.

  • Generalized Anxiety Disorder (GAD)
  • Definition and Diagnostic Criteria

Generalized Anxiety Disorder is characterized by excessive anxiety and worry about a variety of topics, events, or activities, occurring more days than not for at least 6 months . The anxiety must be difficult to control and associated with three or more of the following physical or cognitive symptoms (only one is required in children):

Restlessness or feeling keyed up/on edge.

Being easily fatigued.

Difficulty concentrating or mind going blank.

Irritability.

Muscle tension.

Sleep disturbance (difficulty falling or staying asleep, or restless, unsatisfying sleep).

Management

First-line Pharmacotherapy : SSRIs (escitalopram, paroxetine) or SNRIs (venlafaxine).

Alternative Agents :

Buspirone : A selective 5-HT1A receptor partial agonist. It is unique because it does not cause sedation, cognitive impairment, or physical dependence, and it has no abuse potential. However, it takes 2-4 weeks to become effective, making it useless for acute anxiety.

Beta-blockers (Propranolol) : Excellent for performance anxiety or autonomic symptoms (tremors, palpitations) but does not treat the underlying psychic anxiety.

Psychotherapy : CBT is the gold-standard non-pharmacologic treatment, focusing on worry-exposure and relaxation techniques.

  • Post-Traumatic Stress Disorder (PTSD)
  • Pathophysiology and Clinical Criteria

PTSD develops following exposure to a traumatic event involving actual or threatened death, serious injury, or sexual violence. The diagnosis requires symptoms from four distinct clusters to persist for at least 1 month :

Intrusion Symptoms (at least 1): Recurrent, involuntary, and intrusive distressing memories, dreams, flashbacks (dissociative reactions), or intense psychological/physiological distress at exposure to cues.

Avoidance (at least 1): Avoiding distressing memories, thoughts, feelings, or external reminders (people, places, conversations) associated with the event.

Negative Alterations in Cognition and Mood (at least 2): Inability to remember key aspects of the trauma, persistent negative beliefs about oneself or the world, distorted blame, persistent negative emotional states, anhedonia, and feelings of detachment.

Alterations in Arousal and Reactivity (at least 2): Irritable behavior/angry outbursts, reckless/self-destructive behavior, hypervigilance, exaggerated startle response, concentration problems, and sleep disturbance.

PANCE Timeline Trap : If the patient meets all symptomatic criteria but the symptoms have lasted less than 1 month , the correct diagnosis is Acute Stress Disorder (ASD) . ASD can only be diagnosed between 3 days and 1 month post-trauma.

Management

First-line Pharmacotherapy : SSRIs (specifically sertraline and paroxetine are FDA-approved).

Nightmare Management : Prazosin , an alpha-1 adrenergic receptor antagonist, is highly effective for reducing trauma-related nightmares and sleep disturbances by blocking central noradrenergic hyperactivity.

Psychotherapy : Trauma-focused psychotherapies, specifically Cognitive Processing Therapy (CPT) , Prolonged Exposure (PE) , and Eye Movement Desensitization and Reprocessing (EMDR) , are first-line.

  • Obsessive-Compulsive Disorder (OCD)
  • Definition and Diagnostic Concepts

OCD is characterized by the presence of obsessions, compulsions, or both.

Obsessions : Repetitive, intrusive, unwanted thoughts, images, or urges that cause significant anxiety or distress. The patient typically attempts to ignore, suppress, or neutralize them.

Compulsions : Repetitive behaviors (e.g., handwashing, ordering, checking) or mental acts (e.g., counting, repeating words silently) that the individual feels driven to perform in response to an obsession, or according to rules that must be applied rigidly. The goal is to reduce anxiety or prevent a dreaded event, though the behaviors are not realistically connected to the threat.

Unlike Obsessive-Compulsive Personality Disorder (OCPD), which is ego-syntonic (the patient views their traits as desirable and rational), OCD is ego-dystonic (the patient recognizes that their obsessions and compulsions are irrational, intrusive, and cause significant distress).

Management

Non-Pharmacologic (First-line) : CBT utilizing Exposure and Response Prevention (ERP) . This therapy exposes the patient to the anxiety-inducing stimulus (e.g., touching a doorknob) and prevents them from performing the compulsion (e.g., washing hands).

Pharmacotherapy : High-dose SSRIs (e.g., fluoxetine, sertraline, fluvoxamine) are first-line.

Refractory Cases : Clomipramine , a tricyclic antidepressant (TCA) with high serotonergic selectivity, is highly effective but reserved as second-line due to its significant anticholinergic side effects, antihistaminic properties, and risk of cardiotoxicity in overdose.

Disorder Key Diagnostic Timeline First-Line Pharmacotherapy High-Yield Symptom or Feature

Panic Disorder Recurrent attacks + ≥1 month of worry SSRIs (long-term); Benzodiazepines (acute) Agoraphobia comorbidity; cardiovascular/respiratory symptoms

  • GAD Excessive worry ≥6 months SSRIs or SNRIs; Buspirone Somatic symptoms (muscle tension, fatigue)
  • PTSD Symptom clusters ≥1 month SSRIs (Sertraline/Paroxetine) Prazosin for nightmares; EMDR therapy
  • Acute Stress Disorder Symptoms present 3 days to 1 month Supportive care; CBT Mimics PTSD but limited duration

OCD Time-consuming (>1 hour/day) High-dose SSRIs; Clomipramine (refractory) Ego-dystonic; Exposure and Response Prevention (ERP)

Classic PANCE Traps & Clinical Pearls

The ASD vs. PTSD Timeline : This is a classic question. A patient with nightmares and flashbacks 2 weeks after an accident has Acute Stress Disorder, not PTSD. The timeline must exceed 1 month for PTSD.

Ego-Dystonic vs. Ego-Syntonic : In OCPD, the patient is a neat freak who wants everyone else to follow their rules (ego-syntonic). In OCD, the patient hates their rituals (e.g., checking locks 50 times) but feels compelled to perform them to relieve crushing anxiety (ego-dystonic).

Buspirone Delayed Onset : A patient requesting immediate relief for a panic attack should not be started on buspirone monotherapy, as it takes weeks to work. Use benzodiazepines for immediate distress, and SSRIs for long-term control.